HOME >> BIOLOGY >> NEWS
Tomorrow's super robots may owe their mobility to a cockroachs legs today

hysiological Society (APS) August 24-28, 2002 at the Town & Country Hotel, San Diego, CA. To learn more about the conference and presentations, go to: http://www.the-aps.org/meetings/aps/san_diego/home.htm

Methodology

Relaxation and dynamic experiments were carried out on the hind leg of Blaberus discoidalis to aid in the selection of a material behavior model and to quantify measures of roach leg response. During testing, the coxa of the ablated metathoracic limb (hind limb) of the cockroach was epoxied to 3/8" acrylic such that the coxa-femur and femur-tibia joints were free to rotate. Cyanoacrylate was used to attach one end of a stainless steel pin to the distal tip of the tibia; dental impression compound was used to adhere the other end of the pin to the arm of a servo-motor system. The leg was then displaced with the Aurora system, which is based upon a high performance rotary moving coil motor supported by precision ball bearings. The results are that the total error in the force-displacement measurements to be less than four percent that of a viscoelastic solid.

Results

The results indicate that a cockroach leg excited in a direction orthogonal to the joint direction behaves similarly to a viscoelastic material. The exponential nature of the force relaxation curves suggests viscoelasticity. The hysteretic nature of the force-displacement curves indicates that there is energy loss due to the internal friction, which is a common characteristic for viscoelastic materials. The cockroach leg is subject to a combination of bending and torsion in the experiment. The overall effect can be modeled as a torsion spring with a moment arm. Additional assumptions for the model include: (1) the axis of rotation for the leg is constant during torsion and (2) the joint material can be approximated using a lumped-parameter element with uniformly distributed linear viscoelastic p
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-967-2751
American Physiological Society
26-Aug-2002


Page: 1 2 3 4 5

Related biology news :

1. Sandia Decontamination Foam May Be Tomorrows Best First Response In A Chem-Bio Attack
2. Gene chips research in cotton could lead to superior variety
3. Flame retardants found on supermarket shelves
4. UCSD biologists develop super-endurance strain of mice
5. Birds show superior listening skills
6. Scientists question reports of massive ant supercolonies in California and Europe
7. Knock out rose receives Texas superstar and earthkind designation
8. Frog skin and supercomputers lead Penn chemists to designing better bacteria killers
9. A possible new form of supersolid matter
10. St. Jude ranked among top 500 supercomputer centers
11. Gene mutation leads to super-virulent strain of TB

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tomorrow super robots may owe their mobility cockroachs legs today

(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... 2015 Research and ... of the "Global Biosimilars Market, 2015 - ... The Global Biosimilars Market, 2015 - 2025, report ... biosimilars market. With the blockbuster biologics losing patent ... biosimilars are being viewed as viable substitutes to ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
(Date:7/29/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... an optimized Erk inhibitor molecule for development, thus ... a new class of potential cancer therapies. ... target for therapeutic intervention in cancer. Recently approved ... for B-Raf and Mek inhibitors. Erk inhibitors may ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: